PPH - Big Pharma earnings season in spotlight amid positive sentiment
2024-01-28 12:00:53 ET
More on Amgen, Vertex Pharma, etc.
- Biotech And Pharma Diversification Pays Off
- Up 40%, 3%-Yielding Amgen Is Still One Of My Favorite Healthcare Stocks
- Vertex And Crispr: Second Casgevy Approval Pushes Revenue Potential Into Multi-Billion Dollar Range
- Canaccord cuts Vertex to sell, cites recent price run-up
- FDA issues boxed warning for Amgen's osteoporosis drug